Introduction
Dupuytren’s Disease, also known as Dupuytren’s Contractures, palmar fascitis, Viking Disease, or palmar fibromatosis, is a hand deformity that usually develops slowly, usually over years. This disease is caused by the thickening and contraction of the palmar fascia. As the disease progresses, nodules progress to form longitudinal bands referred to as cords on the palmar fascia, and the finger gradually loses extension, with contractures that draw one or more fingers into flexion at the metacarpophalangeal (MCP) joint, proximal interphalangeal (PIP) joint, or both of these joints.
The cause of Dupuytren’s contracture is unknown, although, important factors include genetics, ethnicity, sex, and age and may include certain environmental factors and other diseases. It is a genetic autosomal dominant disease, and almost always involves people of northern European descent. Dupuytren's contracture most commonly affects the ring finger and pinky. The disease most commonly affects men older than the age of 40. It also appears to affect others with epilepsy, diabetes, pulmonary disease, or alcoholism, although the link between these various diseases is not completely understood.
The flexor tendons are not involved, although it may appear so in advanced contractions. Trauma may accelerate and in some cases even begin the process.
Epidemiology
In affected patients up to 68 percent of their male offspring will develop the disease. Dupuytren disease is relatively common in the United States with a prevalence of 4%, reflecting strong immigration from Northern Europe. Outside of the USA the disease is even more common. In Northern Europe the prevalence ranges from 4-39%. In Norwegian populations 30% of males over...
... middle of paper ...
...tments can relieve some disability but that they cannot completely alleviate all symptoms. In addition, intense rehabilitation with an occupational therapist is often necessary after treatment for optimal benefit and relief of symptoms.
Works Cited
Mayo Clinic Staff. "Dupuytren's Contracture." Mayo Clinic. Mayo Foundation for Medical Education and Research, 24 Oct. 2012. Web. 14 Dec. 2013.
Snider, Robert K. "Dupuytren's Disease." Essentials of Musculoskeletal Care. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1997. 198-99. Print
Dr. Aggarwal, Rohit, and Dr. Philip E. Blazar. "Dupuytren's Contracture." UptoDate. Wolters Kluwer Health, 5 Dec. 2013. Web. 14 Dec. 2013.
Dr. Matthew, Stephanie Danielle. "Dupuytren Contracture ." Dupuytren Contracture. WebMD, 19 Apr. 2013. Web. 14 Dec. 2013.
Also evident are molluscoid pseudotumors (fleshy lesions associated with scars) frequently found over pressure points (e.g. elbows) and subcutaneous spheroids, which are commonly mobile and palpable on the forearms and shins. Complications of joint hypermobility include sprains, dislocation are common in the shoulder, patella and temporomandibular joints Muscle hypotonia and slower gross motor development also can occur It is inherited in an autosomal dominant manner (Clarke, D., Skrocki-Czerpak, K., Neumann-Potash, L.). In the Hypermobile type of EDS, the joints of the body experience Hypermobility, which is the dominant clinical manifestation. General joint hypermobility affects large (elbows, knees) and small (fingers and toes) joints. Skin is hyperextensible, smooth/velvety, and bruising occurs easily as well.
...hromosome and the disease/disorder is passed down in an X linked recessive fashion. Symptoms include muscle weakening and wasting, and pain in the lower body. Mostly only the lower body’s muscles are affected causing the child to have to be confined to a wheelchair. The best way to diagnose Duchenne Muscular Dystrophy is by doing a muscle biopsy to test for abnormal dystrophin levels. There is no treatment for the disease/disorder itself, but only for the symptoms of it. The average age of death in males with Duchenne Muscular Dystrophy is the late thirty’s. Most deaths are caused by breathing complications or heart problems like cardiomyopathy. Duchenne Muscular Dystrophy on average affects one in thirty five hundred male births worldwide. Overall, Duchenne Muscular Dystrophy is very hard to live with and affects many boys around the world.
National Institute of Arthritis and Musculoskeletal and Skin Diseases. "Hidradenitis Suppurativa: MedlinePlus." Nlm.nih.gov/. U.S. National Library of Medicine, n.d. Web. .
Kielhofner (2009) states “In the late 1940’s and the 1950s, occupational therapy came under pressure from medicine to establish a new theoretical rationale for its practice. Critiques arose from both Medicine and physicians regarding the concepts used in occupational therapy. Based on those comments, occupational realized the immediate need for a new paradigm. As Kielhofner mentioned “Occupational therapist came to believe it would bring occupational therapist recognition as an efficacious medical service and increase its scientific respectabilities
Paget’s disease (PD), also known as osteitis deformans, is considered to be an osteometabolic disorder. It can be described as a focal disorder of accelerated and disorganized skeletal remodeling that may affect multiple bones in the body, giving rise to progressive enlargement and deformity of the bones and joints.1 PD is prevalent across both the sexes with incidence ranging from 1.5% to 8%.2 It is more common in individuals over 50 years of age.
After a person reads this article, I can highlight some of the main points in the article to give them a better understanding of what is occupational therapy is in the psychosocial aspect. It is important for me to keep this article on hand because if someone wants to look up what I do and they do not know where to begin, I can give them this article to read to get a basic understanding of what I do and they can get an idea of what to research. This article is not only for clients and client’s friends and family, but it can be used for occupational therapists and occupational therapy assistances. This article can be used as a refresher for a therapist if they are having a hard time remembering something about this
Philip Mortimer BMJ: British Medical Journal , Vol. 321, No. 7269 (Nov. 4, 2000) , p. 1123
Occupational therapy was based off of psychology; we evolved from treating mentally ill patients with isolation as an efficient treatment plan. We must never forget we are known to be “the art and science of helping people do the day-to-day activities that are important and meaningful to their health and well being through engagement in valued occupations” (Crepeau, Cohn, & Schell, 2008). To other professional disciplines this article explains the difference between each of us, yet can also express our relation to one another. The basic goal of all therapeutic disciplines is to better our clients life, through physical, speech or occupational therapy. Every discipline targets different goals, may it be body mechanics, reducing a stutter or buttoning a shirt, at the end of the day our clients well being may it be through science, art or both is all that matters. To the occupational therapy field this article means progress for what we do. Reading this article today in the year 2015 did not seem like old information to me, it is still relevant, I am proud that our field is not only evolving with contemporary time but it is also maintaining its
The first historical account of muscular dystrophy was identified by Sir Charles Bell in 1830. He wrote about a disease that caused weakness in boys that progressively got worse. In 1836 another scientist whose name is unknown reported about two brothers who developed muscle damage, generalized weakness. Also damaged muscle was replaced with fat and connective tissue. At the time the symptoms were thought to point to tuberculosis. During the 1850s reports of boys with progressive muscle weakness became more and more common. There were also reports of these boys losing the ability to walk and dying at an early age. In the next decade French neurologist Guillaume Duchenne gave and in depth account of 13 boys who had the most common ...
The Merck Manuals. (2008). The Merck Manuals. Retrieved from The Merck Manuals Online Medical Library: http://www.merckmanuals.com/home/ag/sec07/ch107/ch107b.html
Ware, Mark. Canadian Medical Association Journal. webmd.com. N.p. 30 August 2010. Web. 4 May 2014.
U.S. National Library of Medicine, 26 Sept. 2011. Web. The Web. The Web. 19 Nov. 2013.
JAMA: Journal of the American Medical Association. 14 Nov. 2001: 2322. Academic Search Complete. Web.
Ed. David Zieve. U.S. National Library of Medicine, 26 Feb. 2014. Web. The Web.